STOCK TITAN

Kiniksa Pharmaceuticals International, plc (KNSA) Total Assets by Year

KNSA NASDAQ

Kiniksa Pharmaceuticals International, plc closed fiscal year 2025 with $763.6M in total assets, $196.0M in total liabilities and $567.6M in shareholder equity. Total assets rose 31.5% from the prior fiscal year. The table below carries 9 fiscal years, from 2017 to 2025, and the quarters Kiniksa Pharmaceuticals International, plc has filed alongside them.

FY2025 annual
Total Assets $763.6M
Total Liabilities $196.0M
Total Equity $567.6M
YoY +31.5%
5Y CAGR +16.9%
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

KNSA Balance Sheet by Fiscal Year

Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY19FilingFY1810-KFY1710-K
Total Assets$763.6M+31.5%$580.6M+10.3%$526.3M+14.5%$459.7M+97.5%$232.8M-33.4%$349.5M+37.3%$254.5M-20.9%$322.0M+577.9%$47.5M
Total Liabilities$196.0M+37.9%$142.1M+62.5%$87.5M+37.7%$63.5M+33.0%$47.8M+27.3%$37.5M+28.9%$29.1M-31.8%$42.7M-68.9%$137.2M
Total Equity$567.6M+29.5%$438.4M-0.1%$438.8M+10.8%$396.1M+114.1%$185.0M-40.7%$311.9M+38.4%$225.4M-19.3%$279.3Mn/m-$89.7M

KNSA Balance Sheet by Quarter

Figures are in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-K
Total Assets$983.2M+38.0%$896.1M+35.5%$825.3M+37.7%$763.6M+31.5%$712.3M+28.3%$661.1M+21.9%$599.3M+15.3%$580.6M+10.3%$555.3M+15.0%$542.4M+12.0%$519.7M+17.3%$526.3M+14.5%
Total Liabilities$273.1M+54.3%$242.0M+45.6%$219.6M+54.8%$196.0M+37.9%$176.9M+49.6%$166.1M+54.8%$141.8M+61.6%$142.1M+62.5%$118.3M+51.8%$107.3M+47.7%$87.8M+66.4%$87.5M+37.7%
Total Equity$710.2M+32.7%$654.1M+32.1%$605.7M+32.4%$567.6M+29.5%$535.4M+22.5%$495.0M+13.8%$457.5M+5.9%$438.4M-0.1%$437.0M+7.9%$435.1M+5.7%$431.9M+10.7%$438.8M+10.8%

What total assets means

Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.

More Kiniksa Pharmaceuticals International, plc financials

Frequently Asked Questions

Kiniksa Pharmaceuticals International, plc closed fiscal year 2025 with $763.6M in total assets, $196.0M in total liabilities and $567.6M in shareholder equity.

Kiniksa Pharmaceuticals International, plc (KNSA) total assets rose by 31.5% year over year, from $580.6M to $763.6M in fiscal year 2025.

Across the 9 fiscal years this page covers, Kiniksa Pharmaceuticals International, plc (KNSA) total assets went from $47.5M in fiscal year 2017 to $763.6M in fiscal year 2025.

Kiniksa Pharmaceuticals International, plc (KNSA) reported $983.2M in total assets in Q3 2026. This represents an increase of 38.0% from the same quarter a year earlier.

Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Kiniksa Pharmaceuticals International, plc (KNSA) reported on that line in every period on record.